A Trial Evaluating the Safety and Immunogenicity of 3 COVID-19 SARS-CoV-2 RNA Vaccines in Healthy Adults

NCT05037097 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19
SARS-CoV-2 Infection
Corona Virus Infection

Interventions

BIOLOGICAL: ARCT-165
BIOLOGICAL: ARCT-154
BIOLOGICAL: ARCT-021

Sponsor

Arcturus Therapeutics, Inc.